Table 3.

Overall survival and disease-free survival multivariate analysis according to clinicopathological factors in 159 NSCLC patients

Variables	Overall survival		Disease-free survival
	HR (95% CI)	P	HR (95% CI)	P
Female	1.308 (0.858–1.994)	0.212	1.355 (0.896–2.047)	0.150
TNM stage	2.021 (1.52–2.682)	<0.001	1.947 (1.481–2.558)	<0.001
HBXIP expression	1.763 (1.114–2.793)	0.016	1.865 (1.198–2.904)	0.006

HR, hazard ratio; CI, confidence interval; TNM, tumor/node/metastasis.